TISMOO is a biotechnology company of global relevance, committed to improving the quality of life of patients and families affected by neurological disorders such as ASD – Autism Spectrum Disorder – and other neurological disorders of genetic origin related to ASD, such as Rett, CDKL5, Timothy Syndrome, Fragile X Syndrome, Angelman Syndrome, Phelan-McDermid Syndrome, among others. At Tismoo, we seek to offer truly innovative technologies that have the potential to change the quality of life for our patients effectively.
Watch our video and learn more about TISMOO!
Where are we going?
When we founded Tismoo, our vision was that, through the combination of science and technology, we could improve and accelerate innovations, to allow thousands of families impacted by Autism and other neurological disorders of genetic origin around the world to diagnose, care for and take care of their children in an increasingly faster, more efficient and less painful way. Building this new model of personalized medicine, to bring more quality of life to these families, is our daily mission.